Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion type Assertion NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_head.
- NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion description "[To identify a gp100 epitope restricted by the MHC class II allele with the highest prevalence in patients with malignant melanoma (HLA-DRB1*0401), we immunized mice transgenic for a chimeric human-mouse class II molecule (DR4-IE) with recombinant human gp100 protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_provenance.
- NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion evidence source_evidence_literature NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_provenance.
- NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion SIO_000772 10725708 NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_provenance.
- NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion wasDerivedFrom befree-20140225 NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_provenance.
- NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_assertion wasGeneratedBy ECO_0000203 NP906953.RAoGJ4GkcryTxeEgOn_rknwF7VKYKGRbY1a8Msgh6ftFQ130_provenance.